Accordingly, our work uncovered that NEK2 is a novel positive modulator of Wnt1 and provided new insights into the molecular mechanisms by which NEK2 participates in oncogenesis and radioresistance in cervical cancer. The gene discussed is WNT1; the disease is cervical carcinoma.